Showing results (221-230 of 1,343) with videos related to
Sort By:
Pageof 135
The Pharmacogenomics Journal|April 23, 2014
Ancestry-based pharmacogenomics, adverse reactions and carbamazepine: is the FDA warning correct?P W PayneThe Pharmacogenomics Journal|April 23, 2014
Association of PAX4 genetic variants with oral antidiabetic drugs efficacy in Chinese type 2 diabetes patientsM Chen, C Hu, R Zhang, et al.The Pharmacogenomics Journal|April 12, 2012
Genome-wide association analysis implicates the involvement of eight loci with response to tocilizumab for the treatment of rheumatoid arthritisJ Wang, A T Bansal, M Martin, et al.The Pharmacogenomics Journal|May 2, 2012
Added value of pharmacogenetic testing in predicting statin response: results from the REGRESS trialF H van der Baan, M J Knol, A H Maitland-van der Zee, et al.The Pharmacogenomics Journal|October 1, 2014
In interaction with gender a common CYP3A4 polymorphism may influence the survival rate of chemotherapy for childhood acute lymphoblastic leukemiaA Gézsi, O Lautner-Csorba, D J Erdélyi, et al.The Pharmacogenomics Journal|October 1, 2014
A polymorphism in HLA-G modifies statin benefit in asthmaD Naidoo, A C Wu, M H Brilliant, et al.The Pharmacogenomics Journal|October 8, 2014
Genetic variants of kinase suppressors of Ras (KSR1) to predict survival in patients with ERα-positive advanced breast cancerL Benhaim, W Zhang, T Wakatsuki, et al.The Pharmacogenomics Journal|August 20, 2014
Genetic variation at glucose and insulin trait loci and response to glucose-insulin-potassium (GIK) therapy: the IMMEDIATE trialK L Ellis, Y Zhou, J R Beshansky, et al.The Pharmacogenomics Journal|September 11, 2013
Interpreting the clinical utility of a pharmacogenomic marker based on observational association studiesM J Sorich, M CooryThe Pharmacogenomics Journal|September 4, 2013
The potential impact of pharmacogenetic testing on medication adherenceS B Haga, N M A LaPointePageof 135